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Purpose: The aim of this paper is to define the requirements and describe the design and implemen-
tation of a standard benchmark tool for evaluation and validation of PET-auto-segmentation (PET-
AS) algorithms. This work follows the recommendations of Task Group 211 (TG211) appointed by
the American Association of Physicists in Medicine (AAPM).
Methods: The recommendations published in the AAPM TG211 report were used to derive a set of
required features and to guide the design and structure of a benchmarking software tool. These items
included the selection of appropriate representative data and reference contours obtained from
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established approaches and the description of available metrics. The benchmark was designed in a
way that it could be extendable by inclusion of bespoke segmentation methods, while maintaining its
main purpose of being a standard testing platform for newly developed PET-AS methods. An exam-
ple of implementation of the proposed framework, named PETASset, was built. In this work, a selec-
tion of PET-AS methods representing common approaches to PET image segmentation was
evaluated within PETASset for the purpose of testing and demonstrating the capabilities of the soft-
ware as a benchmark platform.
Results: A selection of clinical, physical, and simulated phantom data, including “best estimates” ref-
erence contours from macroscopic specimens, simulation template, and CT scans was built into the
PETASset application database. Specific metrics such as Dice Similarity Coefficient (DSC), Positive
Predictive Value (PPV), and Sensitivity (S), were included to allow the user to compare the results of
any given PET-AS algorithm to the reference contours. In addition, a tool to generate structured
reports on the evaluation of the performance of PET-AS algorithms against the reference contours
was built. The variation of the metric agreement values with the reference contours across the PET-
AS methods evaluated for demonstration were between 0.51 and 0.83, 0.44 and 0.86, and 0.61 and
1.00 for DSC, PPV, and the S metric, respectively. Examples of agreement limits were provided to
show how the software could be used to evaluate a new algorithm against the existing state-of-the art.
Conclusions: PETASset provides a platform that allows standardizing the evaluation and compar-
ison of different PET-AS methods on a wide range of PET datasets. The developed platform will be
available to users willing to evaluate their PET-AS methods and contribute with more evaluation data-
sets. © 2017 The Authors. Medical Physics published by Wiley Periodicals, Inc. on behalf of Ameri-
can Association of Physicists in Medicine. [https://doi.org/10.1002/mp.12312]
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List of abbreviations
AAPM American Association of Physicists in
Medicine
AL Agreement Limits
AT Adaptive thresholding
BRENPHN Brest Numerical Phantom H&N data
BRENPLU Brest Numerical Phantom Lung data
CERR Computational Environment for Radiotherapy
Research
CT Computed Tomography
DICOM Digital Imaging for COmmunications in
Medicine
DICOM-RT DICOM extension to RadioTherapy
RTSTRUCT DICOM-RT structure data set
DSC Dice Similarity Coefficient
DUV Delineation Uncertainty Volume
FBP Filtered Back-Projection
FLAB Fuzzy Locally Adaptive Bayesian statistical
segmentation method
FT40 Fixed Thresholding at 40% maximum
intensity
FT42 Fixed Thresholding at 40% maximum
intensity
FT50 Fixed Thresholding at 50% maximum
intensity
GATE Geant4 Application for Tomographic Emission
GATE SIM GATE Simulation
GCM Gaussian Clustering Model
GMM Gaussian Mixture Model clustering
GTV Gross Tumor Volume
GUI Graphical User Interface
HD Hausdorff Distance
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H&N Head and Neck
KM K-means clustering
MILPPAB Milan Physical Phantom Abdominal data
MRI Magnetic Resonance Imaging
OSEM Ordered Subset Expectation Maximization
PET Positron Emission Tomography
PET-AS PET-Automatic Segmentation
PETASset PET-AS Suite of Evaluation Tools
PETSTEP PET Simulator of Tracers via Emission
Projection
PPV Positive Predictive Value
PSF Point Spread Function
RC Reference Contour
RG Region-growing
DP Discriminative Power
SBR Signal to Background Ratio thresholding
SD Standard Deviation
SUV Standardized Uptake Value
TG211 Task Group 211 of the AAPM
UCLPTLU UCL patient Lung data
UCLPTHN UCL patient H&N data
VOI Volume Of Interest
WC Watershed-based Clustering
WT Watershed
1. INTRODUCTION
Positron emission tomography (PET) shows great
potential for improving outcomes in cancer patients.1 This
functional imaging modality provides information that can be
used for a variety of clinical applications including patient
staging and prognosis, radiation therapy planning, therapy
monitoring, and the detection/prediction of recurrences or
metastatic disease.2–5 For all these purposes, accurate delin-
eation of the functional tumor volume in PET is of great
importance, and the need for reliable PET-auto-segmentation
(PET-AS) methods has been widely expressed. However,
despite the abundance of developed approaches, there is cur-
rently no established agreement on the most reliable tech-
nique for routine clinical PET-AS use. In addition, there are
currently no universally established protocols or benchmarks
for comparative performance evaluation of such PET-AS
methods for clinical use.
In this context, the report of the American Association of
Physicists in Medicine (AAPM) Task Group 211 (TG211)6
found that the selection of a single method among those
available is a challenging task considering the large number
of published PET-AS algorithms and the variability of
methodological approaches and their associated level of vali-
dation. The task group acknowledged the need for developing
a standard evaluation framework (benchmark) designed for
the assessment of both existing and future PET-AS algo-
rithms. The report also pointed out that the value of a bench-
mark would rely heavily on the choice of testing data, as well
as on the associated performance evaluation metrics.
In this work, we describe the requirements for the design
and implementation of such benchmark and report on the
PET-AS Suite of Evaluation Tools (PETASset) package which
was developed in line with the recommendations of TG211.
2. MATERIALS AND METHODS
In this section, we propose recommendations for standard
features of the benchmark. These can be grouped according
to (a) usability and accessibility, (b) application areas, and (c)
performance criteria.
2.A. Usability and accessibility
In order for a standard to be usable, it is essential that the
software is easy to use and quick to learn, although it is safe
to assume some level of prior knowledge in the field (e.g.,
PET image analysis and segmentation) from the users. In par-
ticular, the user interface is required to be intuitive and
accompanied by comprehensive documentation to guide the
user through common useful cases or specific tasks. In addi-
tion, the software is required to be accessible to the public
and understandable by the targeted user-base. It may be desir-
able also that the design allows the software to be further
extended and used for other applications in the future.
2.B. Application areas
The areas of application of the benchmark relate to the
field of oncology. Image types are expected to reflect the
state-of-the-art in diagnostic imaging and treatment manage-
ment and to adopt the most recent digitized histopathology
methods and bespoke phantoms. The benchmark should be
easily extendable to satisfy the needs of more application
areas according to the availability of new data and new tech-
nology. The types of Volumes of Interest (VOI) included in a
standardized evaluation protocol should at a minimum
include disease sites established for using PET in radiother-
apy treatment planning.
Best estimates of reference contours (RC) may originate
from various sources depending on the image type included
in the dataset. We distinguish between the following types of
RC:
(i) Absolute truth: only available for simulated images.
(ii) Single ‘best’ estimates: surrogate of truth provided
for physical phantom images and in the special case
of patient images for which histopathology data are
available. In physical phantom images, the optimal
threshold in simultaneous CT images provides a
uniquely best estimate but cannot be considered the
absolute truth because of threshold uncertainty aris-
ing from partial volume effects and potential
misalignments between PET and CT datasets. The
accuracy of RC data for patient scans provided by
pathology examination of excised lesions is limited
due to specimen deformation during processing and
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possible metabolic changes between the time of scan
and the time of excision.7
(iii) Multiple equally ‘best’ estimates: they can be pro-
vided in the form of consensus manual expert delin-
eations when no single delineation can be considered
to be the best.
2.C. Performance criteria
This section describes the outputs expected from a bench-
mark in terms of both segmentation results and subsequent anal-
ysis using quantitative metrics extracted from the images. The
benchmark is required to evaluate the agreement of PET-AS
results with the best available ‘truth’ estimate, as well as their
robustness and the clinical implications of segmentation inaccu-
racies. The term ‘agreement’ relates to both volumetric and geo-
metric properties. This is in line with the end-points defined in
the TG211 report, which includes “the spatial distribution of the
tracer obtained from the PET image after correcting for physical
artifacts” (cf. Ref. [6], section 4.A). Performance criteria for seg-
mentation methods can include:6,8
(i) Accuracy: ability to recover the true tumor contour
(ii) Reproducibility: ability to provide the same result
when used multiple times on the same image
(iii) Efficiency: ability to minimize computational com-
plexity and workflow
(iv) Robustness: ability to provide similar results under
varying acquisition and image reconstruction
conditions
In the case of PET-AS methods that rely on a pure auto-
matic approach without user intervention, the reproducibility
is expected to be 100%, and the efficiency including human
and computational resources required for the segmentation is
expected to be high due to the automatic process. Hence, it is
suggested that the benchmark evaluation tools should focus
on accuracy and robustness of the PET-AS methods. Follow-
ing these requirements, the accuracy metrics to be included
in the benchmark are grouped into three categories, corre-
sponding to increasing degrees of complexity:
• Level I: metrics that assess the agreement in terms of
volumetric properties such as the number of voxels in
the VOI and the statistics of PET signal integrated over
that volume
• Level II: metrics that quantify the geometric agreement
including spatial matching between a particular PET-
AS contour and the RC
• Level III: metrics that evaluate the clinical relevance of
the disagreement between PET-AS contours and RCs.
These metrics describe the “knock-on” effect that seg-
mentation inaccuracy has on parameters used in treat-
ment selection and planning and, in the case of external-
beam radiotherapy, dose delivery. This functionality is
expected to ultimately be related to treatment outcome
and is not implemented in the first release of this bench-
mark.
The robustness metrics should include, as suggested by
Hatt et al.,9 the analysis of the sensitivity to the following
variations:
(i) across datasets, governed by differences in anatomy
and physiology as reflected by the image characteris-
tics,
(ii) within a dataset, resulting from natural differences in
gross tumor volume shape/size between different
patients, and
(iii) within an image, according to differences in image
reconstruction and noise levels across different real-
izations of that image.
2.D. Recommendation for standard requirements
The following components and functionalities are desir-
able for the benchmark software:
A1: Open access to the software and functionalities that are
understandable by both developers and users of the segmen-
tation methods.
A2: Collection of datasets representing the clinical applica-
tions requiring validation of PET-AS methods.
A3: Carefully selected images and RCs checked to only
include cases that can provide meaningful metric values.
A4: Capability to allow future extensions by adding new
datasets.
A5: Implementation of PET-AS methods representing the
current state-of-the-art, as described in ref. 6.
A6: Capability to facilitate the addition of an algorithm that
is developed outside the application’s framework and that
can be used to segment images and produce contours in a
format compatible with the benchmark analysis routines.
A7: Metrics to quantify the agreement between PET-AS vol-
umes and RCs and to evaluate the clinical implications of
segmentation inaccuracies.
A8: Functionalities allowing the evaluation of robustness of
PET-AS methods.
A9: Ability to directly compare the accuracy of the segmen-
tation of:
(i) the same image using different PET-AS methods
(ii) different images using the same PET-AS method.
2.E. Evaluation of the benchmark
The evaluation of the benchmark aims at addressing the
following question: how good are the chosen datasets and
metrics at quantifying and comparing the performance of
PET-AS methods? The implicit hypothesis is that the collec-
tion of images and metrics provided with the benchmark is
appropriate and allows comparing PET-AS methods with
enough accuracy and precision to distinguish between the
methods and identify their specific strengths and weaknesses.
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To validate this hypothesis, we need to test both the Dis-
criminative power (DP) and specificity of the benchmark for
differentiating PET-AS methods. DP, which here relates to the
ability to distinguish between two PET-AS methods that are
close in performance, can be tested by evaluating the range of
variation of the performance metrics across the range of PET-
AS methods and images. Specificity, defined here as the abil-
ity of the software to detect changes in performance that are
linked to the difficulty of the segmentation, can be tested by
comparing reference contours with a modified version of
these contours which were prepared to be less accurate.
3. RESULTS
This section summarizes the approach taken to implement
the standard with the PETASset software while satisfying
aims A1 – A9 and the recommendations given in Section 2.
The PETASset code was written in the Matlab language (The
Mathworks Inc, Natick, USA), including the Image Process-
ing Toolbox. PETASset was implemented as a plugin to the
Computational Environment for Radiotherapy Research
(CERR) software.10 This enabled using CERR’s capabilities
for handling and displaying Digital Imaging and Communi-
cations in Medicine (DICOM) data, as well as dealing with
Radiotherapy Treatment (DICOM-RT) data.
PETASset reference data are stored and distributed in a
Matlab structure saved in the CERR file format, and are com-
patible with all the tools available in CERR. This format is
also readable by any other Matlab-based application. An
application programming interface that can be used to read
Matlab formatted data in external environments is also avail-
able and is described elsewhere.† PETASset is freely dis-
tributed along with CERR, for which user documentation is
easily accessible,‡ in line with A1.
The folder structure of the PETASset package and a short
description of its content are given in Fig. 1. A detailed
description of PETASset’s content and functionalities is
given in the following section.
3.A. Data
3.A.1. Datasets
With reference to Fig. 1, the “Data” folder contains the
image datasets (cases) distributed with PETASset. These are
provided in compressed CERR file format. The cases include
phantom and patient scans for three anatomical sites: H&N,
lung, and pelvis. Reference contours were generated using (a)
histopathology specimen, (b) simulation templates, or (c)
another imaging modality (e.g., CT). The reference contours
are considered to be the best estimate of RCs for the cases
provided with PETASset. A total of 66 PET studies with RCs
from four different research centers are currently included in
the PETASset database.
The cases included in each dataset are reported in Table I
and described in more details below:
• UCLPTLU
11: 10 clinical PET/CT lung cases, with two
PET scans corresponding to different spatial sampling,
i.e., different voxel sizes.
• UCLPTHN
12: seven clinical PET/CT H&N cases.
• MILPPAB
13: 11 cases corresponding to successive
acquisitions of the same physical body phantom.
• BRENPLU
14: two simulated PET lung study generated
with the GATE simulation toolkit.15
• BRENPHN
14: six simulated PET H&N cases generated
with the GATE simulation toolkit.
• SIM
16: a total of 30 simulated PET scans, 10 for each of
the sites: pelvis (SIMPTAB), lung (SIMPTLU), and
H&N (SIMPTHN). Each dataset contains two recon-
structions using the Ordered Subset Expectation Maxi-
mization (OSEM) algorithms and OSEM + point spread
FIG. 1. PETASset package structure and content.
†Mathworks homepage https://www.mathworks.com/help/matlab/
programming-interfaces-for-c-c-fortran-com.html
‡CERR homepage http://www.cerr.info
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function (PSF) correction, for five different simulated
structures with different geometry and location. These
data were generated with the PET Simulator tool
described in III.C.4.
The cases were chosen in line with requirement A2, with
the inclusion of both clinical PET/CT used in state-of-the art
treatment management and state-of-the-art phantom data.
According to requirement A8, this set of cases was selected
to allow testing the robustness of the different PET-AS meth-
ods included in PETASset to:
(i) different reconstruction parameters for the same
patient/phantom (UCLPTLU, SIM)
(ii) different acquisitions, with different Signal to Noise
Ratio, of the same physical phantom (MILPPAB)
(iii) different instances of simulated VOIs, generated
according to the selection of different parameters
controlling the image reconstruction process
(BRENPHN).
(iv) different VOI geometries and locations for the same
underlying normal PETuptake (SIM).
The target volumes were chosen in line with requirement
A2, with a focus on lung and H&N cancer. Cutting-edge
histopathology and tissue heterogeneity data, modeled in the
simulated datasets (BRENPLU, BRENPHN, SIM) were also
included.
3.A.2. Reference contours
In PETASset RCs are hidden from the user and are only
used for evaluation purposes.
With reference to Table I, the RCs included in the current
version of PETASset are
• UCLPTHN: 1 RC per series. The contour was derived
from the macroscopic specimen obtained after surgery,
digitized on a flatbed scanner and registered to the CT
scan.11
• UCLPTLU: 1 RC per series. The contour was derived
from the macroscopic specimen obtained after surgery,
digitized on a flatbed scanner and registered to the CT
scan. The same RC is used for both reconstruction
types.12
• MILPPAB: 1 RC per series, for 11 different zeolite
tumor models positioned in various regions of the phys-
ical phantom and six different acquisition instances.
Reference contours were derived from thresholding on
the corresponding CT, iteratively adapted to fit the
known volume.13
• BRENPLU and BRENPHN: 1 RC per series, encom-
passing the whole tumor even in case of heterogeneous
uptake. These contours correspond to the tumors
defined in the original simulation map.14
• SIM data: 1 RC contour per series, extracted from the
original simulation PET uptake map.16
TABLE I. PETASset benchmark datasets.
Dataset Reference Center Data type
Anatomical
region
Number
of studies
Number
of series/study
Number
of structures/
series
Reference
contour CT data Additional features
UCLPTLU Wanet et al.11 Universite
catholique
de Louvain
Patient Lung 10 2 1 Specimen Yes 2 voxel sizes/PET
scan
UCLPTHN Daisne et al.12 Patient H&N 7 1 1 Specimen No –
MILPPAB Zito et al.13 Fondazione
IRCCS
Ca’ Granda
Ospedale
Maggiore
Policlinico
Phantom Lung &
Pelvis
11 6 1 CT No Different
acquisition
instances
BRENPHN Hatt et al.14 LaTIM,
INSERM
Phantom H&N 6 1 1 Simulation No Heterogeneous
(2 RC contours)
BRENPLU Phantom Lung 2 1 1 Simulation No Heterogeneous
(2 RC contours)
SIMPTLU Berthon et al.16 MSKCC/
Cardiff
University
Patient Lung 10 5 1 Simulation No 5 RC geometries/
2 reconstructions/
5 acquisition
instances
SIMPTHN Patient H&N 10 5 1 Simulation No 5 RC geometries/
2 reconstructions/
5 acquisition
instances
SIMPTAB Patient Pelvis 10 5 1 Simulation No 5 RC geometries/
2 reconstructions/
5 acquisition
instances
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Figure 2 shows examples of the PET images available in
PETASset including the associated RCs.
3.B. Workﬂow and analysis
The workflow implemented in PETASset is shown in
Fig. 3 and includes:
(i) Image and VOI visualization
(ii) Image segmentation
(iii) Data analysis and evaluation of performance metrics
(iv) Structured reporting
The input to PETASset is a set of contours the accuracy of
which has to be evaluated. The contours can be generated
using the (a) default PET-AS methods provided with PETAS-
set, (b) the segmentation module available in CERR or (c)
custom Matlab code (cf. Fig. 1).
A number of different analyses can be carried out in
PETASset as shown in Fig. 4. Depending on the used
dataset and evaluation metric, a given PET-AS method
can be tested in terms of absolute accuracy and/or in
terms of robustness to a specific reconstruction parameter.
For instance, testing a PET-AS method on UCLPTLU
data with Level I and II metrics provides a quantitative
measure of its performance on clinical lung tumor data.
In addition, the robustness of a PET-AS method to differ-
ent image acquisitions of the same subject can be
assessed using the MILPABB dataset as the standard
deviation of results obtained for the same lesions over
the different acquisition instances available.
All evaluation strategies, represented by Level I-II metrics,
operate on three types of data:
• PET image
• User-generated contours
• Reference contour
It is worth noting that in PETASset all RCs and PET-AS
contours in each study are defined in the same frame of refer-
ence and in the same co-ordinate grid as the image space and
resolution of the PET data are used. The evaluation strategies
implemented in PETASset are described in Section 3.C.2.
3.C. Code
With reference to Fig. 1, the PETASset code system is
saved in the “Code” folder. All the code files (or functions),
(a) (b)
(c) (d)
(f) (g)
(e)
FIG. 2. Examples of PET images and RCs available in PETASset. (a) and (b) UCLPTLU, same lesion with different image resolution; (c) BRENPHN; (d) MILP-
PAB; (e) UCLPTHN; (f) SIMPTAB; (g) SIMPTHN (cf. Table I). [Color figure can be viewed at wileyonlinelibrary.com]
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written in the Matlab language, are accessible from the
PETASset drop-down menu and are separated into three cate-
gories (a) Segmentation, (b) Analysis, and (c) Report
described in detail in the next sections.
3.C.1. Segmentation
The functions in the Segmentation category are used by
the PETASset segmentation tool to segment images and gen-
erate contours. The PETASset segmentation tool is accessible
through a Graphical User Interface (GUI) which allows visu-
alization and segmentation of the current PET scan. Once the
PET scan is selected, PETASset automatically displays axial,
sagittal, and coronal views of the volume on which the RC is
defined. The segmentation algorithm can be then chosen
from a drop-down list. The list includes the PET-AS methods
provided by default with the PETASset package plus any
additional custom algorithm implemented by the user. The
result of the image segmentation can be displayed and saved
together with the information on algorithm and parameters
used. The PET-AS segmentation methods implemented by
default in PETASset include:
• fixed threshold (percentage of maximum)
• fixed threshold (absolute threshold)
• region growing
• statistical clustering
The methods were selected from common thresholding
and advanced methods as defined by Hatt et al.6 (sections
2.B.1 and 2.B.2). It is worth noting that custom segmentation
methods coded in the Matlab language can also be used as
FIG. 4. Analysis workflows implemented in PETASset.
FIG. 3. PETASset workflow for a given study, RC and PET-AS method. [Color figure can be viewed at wileyonlinelibrary.com]
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well as any manual or threshold methods implemented in the
current version of CERR or indeed any third-party PET-AS
method that supports file export to the DICOM RTSTRUCT
format.
3.C.2. Analysis
The functions in the Analysis category implement metrics
used for the evaluation of the agreement between PET-AS-
generated contours and the RC. The code files are grouped in
two folders: Levels I and Level II, which correspond to differ-
ent metrics that can be launched independently from the
PETASset menu. The PETASset analysis tool is also accessi-
ble through a GUI that allows the user to select the PET-AS
contours and the metrics to use in the study. The results of
the analysis are automatically saved to file and can also be
shown in tabular format. Level I and II metrics are described
in the next sections.
Level I: Level I metrics are used to provide basic and
essential information on the delineated VOI. The metrics
include:
• Volume
• Mean uptake value
• Maximum uptake value
• Centre of mass
Each Level I metric can be used to quantify the deviation
between the PET-AS and the RC. Uptake statistics and
absolute volume are scalar quantities and the deviation from
the reference value is given by the signed fractional differ-
ence. The center of mass is a vector quantity and the devia-
tion from the reference value is given by the Euclidean
distance between PET-AS and centers of mass of the RC. If
we denote with A and B, the set of voxels delimited by the
RC and by the PET-AS contours respectively, we can define
the following errors for Level I metrics:
where j j and k k represent set cardinality and the Eucli-
dean norm, respectively.
Level II: Level II metrics are used to quantify the similar-
ity between the PET-AS and the RC. This similarity can be
expressed in terms of geometrical properties and spatial over-
lap. The following metrics were implemented in PETASset:6
• Dice Similarity Coefficient (DSC)
DSC ðA;BÞ ¼
2 jA \ Bj
jAj þ jBj
; range ½0; 1 (5)
• Sensitivity (S)
S ¼
jA \ Bj
jAj
; range ½0; 1 (6)
• Positive Predictive Value (PPV)
PPV ¼
jA \ Bj
jBj
; range ½0; 1 (7)
• Modified Hausdorff Distance (HD)
17
HD ¼ max
1
NA
X
i
minjkai  bjk;
1
NB
X
i
minjkbi  ajk
 
;
range ½0;þ1Þ
(8)
• Delineation Uncertainty Volume (DUV)
DUV ¼ ðjA [ BjÞ  ðjA \ BjÞ; range ½0;þ1Þ (9)
where A and B are the set of voxels delimited by the RC
and by the PET-AS contours respectively, | | represent set
cardinality, and ka bk is the Euclidean distance of point
a on the RC to point b on the PET-AS contour. The range
of values that can be achieved is indicated for each metric.
The metric in Eq. 8 is a variant of the Hausdorff distance
(averages replaces the maximum). This formulation was
implemented in PETASset following the results of
Dubuisson et al.17 showing its superiority compared to the
original algorithm in quantifying the similarity between
two contours. The DUV in Eq. 9 is the cardinality of the
volume between the reference and test surfaces. From
DUV, one can derive the average delineation uncertainty
in voxels (or cm knowing the voxel dimensions) as the
average thickness of this volume.
An example of Level II analysis performed on a single
study (1 RC) of the UCLPTLU dataset is given in
 error in volume ¼
ðjBj  jAjÞ
jAj
 100 ð%Þ (1)
 error in mean uptake ¼
ðmean uptake ðBÞ  mean uptake ðAÞÞ
mean uptake ðAÞ
 100 ð%Þ (2)
 error in maximum uptake ¼
ðmaximum uptake ðBÞ  maximum uptake ðAÞÞ
maximum uptake ðAÞ
 100 ð%Þ (3)
 error in center of mass ¼ kcenter of mass ðBÞ  center of mass ðAÞk (4)
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Table II for metrics DSC, S, PPV, and HD. The PET-AS
methods were: Watershed-based clustering (WC), Signal to
Background Ratio (SBR) thresholding method as described
by Geets et al.18 and fixed thresholding with 40% and
50% of the maximum tumor intensity (FT40 and FT50
respectively). In this case, the RC was extracted from a
digitized macroscopic specimen (cf. UCLPTLU in
Table I). Values obtained for the RC correspond to the
best metric value achievable.
3.C.3. Report
The functions in the Report category are used by the
reporting tool to produce structured reports that summarize
the results of the PETASset analysis. PETASset supports two
types of report: “Local” and “Global”. Both reports can be
generated through dedicated GUIs. PETASset report supports
different output formats (html, pdf, or doc document), which
can also be selected by the user. Both reports are described in
more detail in the following paragraphs.
Local Report: The Local Report is designed to summa-
rize the performance of PET-AS methods for a single study
and a selection of metrics. The structured report contains the
following sections:
(i) PETASset analysis details:
• Name of the image file corresponding to the selected
study
• List of PET-AS contours selected
• List of metrics used in the analysis
(ii) Level I analysis:
• Table of Level I metric values for the selected PET-
AS contours
• Graphs of the values obtained across PET-AS con-
tours for each metric
(iii) Level II analysis:
• Table of Level II metric values for the selected PET-
AS contours
• Graphs of the values obtained across PET-AS con-
tours for each metric
Global Report: The Global Report is designed to include
the performance of PET-AS methods across several cases. It
allows one or more PET-AS methods to be evaluated and
ranked using different performance metrics across the whole
benchmark dataset. The Global Report also provides addi-
tional statistics data such as the mean and standard deviation
of metric values, for each dataset across all the selected cases.
It can also be used for longitudinal studies.
The structure of the Local and Global Reports is the same,
except for one additional section which contains the follow-
ing items:
(i) A table reporting the mean and standard deviation of
each metric value across the selected PET-AS con-
tours
(ii) A table containing mean metric values across cases
within each dataset separately
(iii) Graphs showing the mean and standard deviation
of each metric value across cases within the differ-
ent datasets grouped by data type (clinical, non-
clinical) and tumor site.
3.C.4. 3D PET simulator
The 3D PET simulator PETSTEP§,16 was also imple-
mented in PETASset. With PETSTEP synthetic 3D PET
scans can be generated using the PET or CT data provided
with PETASset. Tumors of any shape, maximum SUV, and
tracer uptake distribution can be added to the original PET or
CT image. Different scanner and reconstruction parameters
can also be set by the user. Currently implemented recon-
struction techniques include Filtered Back-Projection (FBP),
and OSEM algorithms with or without Point Spread Function
(PSF) modeling.19 The PETSTEP functionalities allow users
to generate reference PET and RC data that can be used to test
and optimize their own segmentation methods and/or to test
the robustness of PET-AS methods to a particular image
parameter, reconstruction setting, or acquisition instance.
3.D. Evaluation of the implementation
In line with the evaluation objectives defined in sec-
tion 2.E, we assessed the DP of PETASset to distinguish
eight PET-AS methods including:
• FT42: fixed threshold of 42% maximum intensity
• FLAB: fuzzy locally adaptive Bayesian statistical seg-
mentation method20
• GMM: Gaussian Mixture Model clustering
21
• AT: Adaptive thresholding
22
• RG: Region-growing
22
• KM: K-means clustering
22
• GCM: Gaussian Clustering Model
22
• WT: Watershed
22
TABLE II. Example of Level II analysis using RC data from a single series in
the UCLPTLU dataset and different PET-AS methods.
Method DSC S PPV HD (cm)
RC 1 1 1 0
WC 0.778 0.754 0.804 0.250
SBR 0.642 0.511 0.864 0.318
FT40 0.652 0.525 0.861 0.318
FT50 0.469 0.315 0.920 0.378
§PETSTEP is available for download from: https://github.com/
CRossSchmidtlein/PETSTEP
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Contours were obtained outside PETASset for the meth-
ods not implemented in the software, such as FLAB and
GMM.
Level I and Level II analyses were carried out using the
PETASset functionalities described in Section 3.C.2.
Table III reports the average Level I and Level II metric val-
ues calculated across all RCs with associated standard devia-
tion. The median and standard deviation across all methods is
also reported at the bottom of the table, together with the
range. The standard deviation (SD) of Level I metrics across
PET-AS methods, given with the median value in Table III,
ranged between 40% (absolute error in volume) and 94% (er-
ror in maximum SUV value) of the median value, corre-
sponding to values of 17 and 1.6, respectively. For level II
metrics, SDs ranged between 8.4% (PPV) and 20% (S) of the
median value, corresponding to values of 0.07 and 0.13,
respectively.
PETASset can also provide, for each metric, Agreement
Limits (ALs) to indicate the range of values that can be
expected by a new segmentation method compared to the per-
formance of existing PET-AS methods already evaluated with
PETASset. ALs for example could be defined as the mini-
mum and maximum values of a range corresponding to one
standard deviation centered on the median value (Table III)
or by confidence limits as determined from future research. It
is worth noting that for metrics such as DSC, S, and PPV that
provide a finite measure of agreement, the upper limit of the
AL should be set to the maximum achievable value.
The specificity analysis was carried out by modifying the
PETASset RCs to introduce known inaccuracies, on one of
the UCLPTHN series. The following test contours were gen-
erated to represent typical segmentation errors due to under-
contouring, over-contouring and different contour shape:
(i) isotropic shrinkage of 0.5 cm (RC – 0.5 cm)
(ii) isotropic expansion of x = 0.25, 0.35, 0.45, 0.5,
1.0 cm (RC + x cm)
(iii) iso-volumetric erosion/dilation (the RC was eroded
and dilated locally to modify its geometry while
maintaining the same volume)
where expansions of 0.5 and 1.0 cm were used to model
“moderate” and “large” over-contouring, respectively. All
modified contours were compared to the RC in terms of volu-
metric error, error in mean, DSC, S, PPV, and HD. The
results of this analysis are given in Fig. 5.
Results of the specificity analysis on Fig. 5 provide clear
rankings of the different contours for the different metrics
considered. In terms of the error in volume for example, the
smallest error is obtained for RC eroded, which was designed
to have a volume very close to the RC. The largest error is
obtained by RC + 1 cm, which is also visually the contour
the most different from RC. The sign of the error in volume
also provides information on the type of segmentation error
(over-segmentation or under-segmentation). Because the met-
rics chosen provide complementary information, the respec-
tive rankings are different.
The variations observed across methods and test cases are
considered large enough to conclude that PETASset provides
informative results for the comparison of PET-AS methods,
thereby validating the discriminative power of PETASset. In
addition, PETASset is able to accurately and clearly rank con-
tours with known and different inaccuracies, for example
small variations in volume, which validates its specificity. It
should be noted, however, that the specificity will be limited
by the accuracy of the volume contour definition in CERR.
Furthermore, the specificity, as described here, will vary with
the RC size: larger RCs are expected to lead to smaller differ-
ences between metric values when testing volumes of similar
known volume error.
The results given in Table III are an illustration of how
ALs could be defined, based on the hypothesis that datasets
and PET-AS methods implemented in PETASset are repre-
sentative of the current state-of-the art. In this example, with
reference to Table III, a PET-AS method would be within the
ALs for the volumetric error if its absolute mean error in vol-
ume across the PETASset VOIs was lower than 59% of the
true volume. It would be within the ALs for the DSC, if its
mean DSC across the PETASset was between 0.62 and 1.
However, the ALs provided in this work should not be used
in practice as they were provided only as an illustration of the
TABLE III. Average Level I and Level II metric values calculated across the entire PETASset dataset and associated standard deviation.
Method
Level I Absolute metric error (% RC) Level II
Volume Max SUV Mean SUV DSC S PPV HD (cm)
FLAB 27  15 3.0  12 6.3  11 0.74  0.07 0.69  0.09 0.82  0.09 0.25  0.16
GMM 21  25 5.0  11 0.21  10 0.76  0.08 0.77  0.08 0.78  0.09 0.17  0.12
FT50 60  37 0.89  11 3.7  35 0.53  0.08 0.43  0.11 0.91  0.10 0.30  0.08
FT42 61  70 0.36  9.8 15  20 0.64  0.07 0.56  0.09 0.88  0.09 0.24  0.08
RG 42  21 0.18  12 11  18 0.68  0.07 0.62  0.10 0.85  0.11 0.23  0.10
KM 70  163 2.7  11 11  58 0.73  0.10 0.85  0.05 0.69  0.13 0.27  0.20
GCM 39  13 0.98  9.6 9.0  17 0.70  0.06 0.65  0.09 0.83  0.09 0.19  0.05
WT 42  26 2.5  11 3.3  18 0.67  0.07 0.63  0.11 0.79  0.10 0.22  0.08
Range 21/70 0.18/5.00 0.21/15 0.53/0.76 0.43/0.85 0.69/0.91 0.17/0.30
Median (SD) 42 ( 17) 1.7 ( 1.6) 7.7 ( 4.9) 0.69 ( 0.07) 0.64 ( 0.13) 0.83 ( 0.07) 0.24 ( 0.04)
Agreement limits (example) (0,59) (0,3.3) (0,12.6) (0.62,1) (0.51,1) (0.76,1) (0,0.28)
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PETASset’s capabilities. Further investigation is needed to
systematically assess clinically relevant and acceptable ALs
for the metrics considered in this study.
4. DISCUSSION
4.A. Design and implementation
PETASset was designed and built following AAPM
TG211 report which identified the need for developing a stan-
dard evaluation framework designed for the assessment of
both existing and future PET-AS algorithms including those
derived from supervised machine learning methods.6,23,24
Figure 4 shows the workflows available in PETASset and the
large range of information that can be extracted from the cur-
rent version of the benchmark. It is important to note that,
although a number of datasets and evaluation metrics are
included, PETASset is not required, and therefore not
designed, to evaluate each PET-AS method on all datasets
using all metrics. Such a requirement is unrealistic due to dif-
ferent assumptions made about the datasets by different PET-
AS methods and metrics. For example, a PET-AS method
may operate on hybrid data, which assumes the availability of
both PET and CT datasets. This assumption may hold for a
patient dataset but not for numerical or physical phantoms.
The imaging and RC data available in the current version of
PETASset are intended to represent the state-of-the-art and
have been assembled with the contribution of leading clinical
and research institutions in the field. The PETASset datasets
include RCs for homogeneous (physical and numerical phan-
toms) as well as heterogeneous tracer uptake (numerical
phantom and clinical data). However, we emphasize that in
order to be meaningful, the comparison of PET-AS methods
developed with the same goal should be performed on the
same datasets and according to the same metrics.
We therefore recommend that the overall performance of a
PET-AS method is evaluated on all the PET-ASset data appli-
cable, for a given segmentation method. This can be done via
the automated analysis tool embedded in the software, which
can select the analysis to be carried out according to the seg-
mentation type. For more specific tests, such as robustness to
a particular image reconstruction method, users can follow
the process shown in Fig. 4.
The design of PETASset allows users to evaluate segmen-
tation methods themselves. This can be done either by
importing segmentation contours produced externally, or by
adding a segmentation tool to the benchmark software.
Level II analysis data are the primary output of PETASset
since they are easy to interpret and compare between PET-AS
methods and since spatial accuracy is a main concern. Level I
metrics provide essential information which put Level II results
into context and allow users to make additional considerations
regarding the relevance of the observed contouring errors.
PETASset can provide ALs for all evaluation metrics included
in the package. This can be used to compare the performance of
new and well established PET-AS methods. The quality and use-
fulness of these ALs will depend on the quality of data available
in PETASset, which will need to be regularly updated. It should
be noted that the ALs provided in this document are not recom-
mended for the evaluation of new PET-AS, since they were
derived using a small number of PET-AS methods and a limited
set of images. Further work is needed to produce task-dependent
and reliable ALs for PET image segmentation.
The RC is hidden via encryption in PETASset when the
software is distributed to the user. Even then, there is a risk
that users optimize their segmentation method blindly to
increase the accuracy score of certain algorithms. This opti-
mization may lead to the development of tools that may not
perform well outside the package. This risk could be limited
by restricting in PETASset the recording of results and the
generation of reports to the PET-AS methods that are tested
on all datasets and considering all metrics. Increasing number
and diversity of reference images and contours will also help
reducing this risk.
Constant improvement and maintenance of the PETASset
is needed in order to deal with these challenges.
4.B. Future work
The current version of PETASset is a research tool that
can be reliably used to evaluate the performance of PET-AS
methods against reference RC data. The following additional
FIG. 5. Specificity analysis for the UCLPTHN test case. (a) RC: black, (b) ‘RC 0.5 cm’: yellow, (c) ‘RC + 0.5 cm’: green, (d) ‘RC + 1 cm’: red, and (e) ‘RC
eroded’: magenta. Other contours are not shown for the sake of clarity. [Color figure can be viewed at wileyonlinelibrary.com]
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functionalities are expected to enhance impact of PETASset
in clinical practice:
(i) Web access: provide web access to PETASset data,
tools and statistics including reports for selected data-
sets and segmentation methods.
(ii) Level III Analysis: design and implement metrics to
evaluate the clinical implications of contour accuracy
in radiotherapy treatment planning.25 It is envisaged
that Level III metrics will operate on reference dose
maps calculated using PETASset’s RC and dis-
tributed with the benchmark.
(iii) Reference data: the value of PETASset will be
enhanced by adding more test data including 4D
PET/CT scans and expert consensus VOIs.26 In
particular, including images with highly varying
degrees of tumor size, activity, contrast and resolu-
tion will enable thorough robustness studies in ful-
fillment of requirement A8. It is envisaged that
synthetic datasets generated with PETSTEP will
also help growing the PETASset database, in par-
ticular to include data specifically designed for
testing robustness to the partial volume effect.
(iv) Imaging modalities: PETASset should evolve to
include the next generation of auto-contouring meth-
ods that combine information from different imaging
modalities such as CT and MRI.
(v) Unified performance score: performance metrics are
specific and limited to only certain image or contour
parameters. PETASset could be used to combine
more metrics in a unified score reporting a single per-
formance value. This would be a desirable feature
and research toward such a metric is encouraged.
(vi) Knowledge-based PET segmentation: continuously
adding to the PETASset database standardized data
on the performance of different PET-AS methods will
enable us to start building models and ALs to use as
a baseline for the assessment of new PET-AS algo-
rithms and for the optimal segmentation of virtually
every type of PET image.
5. CONCLUSIONS
We presented the methodology followed to develop
PETASset, a benchmark dedicated to the standardized evalua-
tion of PET-AS methods. The benchmark provides a common
software platform and state-of-the-art reference data that will
be made publicly available. In line with recommendations of
AAPM TG211, PETASset addresses the need to provide a
framework for an internationally developed standard for the
evaluation of PET-auto-segmentation approaches.
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